Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$165.67 - $199.94 $441,676 - $533,040
2,666 Added 12.32%
24,303 $4.11 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $2.05 Million - $2.71 Million
13,547 Added 167.45%
21,637 $4.27 Million
Q3 2023

Nov 03, 2023

BUY
$167.14 - $192.77 $316,563 - $365,106
1,894 Added 30.57%
8,090 $1.41 Million
Q2 2023

Aug 04, 2023

BUY
$160.94 - $186.23 $88,677 - $102,612
551 Added 9.76%
6,196 $1.07 Million
Q1 2023

May 01, 2023

BUY
$145.48 - $175.02 $105,182 - $126,539
723 Added 14.69%
5,645 $939,000
Q4 2022

Feb 07, 2023

BUY
$131.14 - $157.47 $288,245 - $346,119
2,198 Added 80.69%
4,922 $721,000
Q3 2022

Nov 03, 2022

BUY
$148.29 - $182.55 $31,437 - $38,700
212 Added 8.44%
2,724 $404,000
Q2 2022

Aug 02, 2022

BUY
$155.97 - $200.09 $57,708 - $74,033
370 Added 17.27%
2,512 $432,000
Q1 2022

May 09, 2022

BUY
$181.39 - $234.03 $129,331 - $166,863
713 Added 49.9%
2,142 $404,000
Q4 2021

Jan 26, 2022

SELL
$193.69 - $247.03 $19,562 - $24,950
-101 Reduced 6.6%
1,429 $348,000
Q3 2021

Nov 05, 2021

SELL
$189.29 - $209.69 $96,727 - $107,151
-511 Reduced 25.04%
1,530 $297,000
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $36,168 - $43,613
232 Added 12.82%
2,041 $380,000
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $36,576 - $43,025
254 Added 16.33%
1,809 $285,000
Q4 2020

Feb 05, 2021

SELL
$157.07 - $174.35 $17,434 - $19,352
-111 Reduced 6.66%
1,555 $257,000
Q3 2020

Nov 09, 2020

BUY
$137.1 - $165.37 $228,408 - $275,506
1,666 New
1,666 $276,000
Q2 2018

Aug 08, 2018

SELL
$79.9 - $89.2 $328,788 - $367,058
-4,115 Closed
0 $0
Q1 2018

May 09, 2018

BUY
$71.51 - $84.69 $24,956 - $29,556
349 Added 9.27%
4,115 $343,000
Q4 2017

Feb 13, 2018

BUY
$63.24 - $72.8 $238,161 - $274,164
3,766
3,766 $272,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.